| Primary |
| Hypertension |
30.2% |
| Atrial Fibrillation |
12.1% |
| Essential Hypertension |
10.3% |
| Drug Use For Unknown Indication |
6.9% |
| Superinfection |
5.2% |
| Diabetes Mellitus |
4.3% |
| Pain |
4.3% |
| Hiv Infection |
3.4% |
| Cardiomyopathy |
2.6% |
| Dementia Alzheimer's Type |
2.6% |
| Depression |
2.6% |
| Type 2 Diabetes Mellitus |
2.6% |
| Atrial Flutter |
1.7% |
| Chlamydial Infection |
1.7% |
| Dyslipidaemia |
1.7% |
| Gastrointestinal Disorder |
1.7% |
| Gout |
1.7% |
| Musculoskeletal Pain |
1.7% |
| Osteoarthritis |
1.7% |
| Anxiety |
0.9% |
|
| Malaise |
13.3% |
| Vomiting |
13.3% |
| Hyponatraemia |
8.9% |
| Orthostatic Hypotension |
8.9% |
| Renal Failure Acute |
8.9% |
| Renal Failure |
6.7% |
| Hepatitis Fulminant |
4.4% |
| Nephritis Allergic |
4.4% |
| Pemphigoid |
4.4% |
| Syncope |
4.4% |
| Cardiac Failure |
2.2% |
| Cerebral Haematoma |
2.2% |
| Confusional State |
2.2% |
| Eczema |
2.2% |
| Exposure During Pregnancy |
2.2% |
| Foetal Malformation |
2.2% |
| Generalised Oedema |
2.2% |
| Hyperkalaemia |
2.2% |
| Inappropriate Antidiuretic Hormone Secretion |
2.2% |
| Interstitial Lung Disease |
2.2% |
|
| Secondary |
| Drug Use For Unknown Indication |
21.1% |
| Hypertension |
17.8% |
| Product Used For Unknown Indication |
11.7% |
| Atrial Fibrillation |
10.6% |
| Cardiomyopathy |
3.3% |
| Psychotic Disorder |
3.3% |
| Sepsis |
3.3% |
| Diabetes Mellitus |
2.8% |
| Essential Hypertension |
2.8% |
| Ill-defined Disorder |
2.8% |
| Superinfection |
2.8% |
| Depression |
2.2% |
| Hiv Infection |
2.2% |
| Pain |
2.2% |
| Prophylaxis |
2.2% |
| Rheumatoid Arthritis |
2.2% |
| Type 2 Diabetes Mellitus |
2.2% |
| Chlamydial Infection |
1.7% |
| Hypothyroidism |
1.7% |
| Anxiety |
1.1% |
|
| Hyponatraemia |
17.4% |
| Syncope |
8.7% |
| Vomiting |
8.7% |
| Hepatitis Fulminant |
6.5% |
| Nephritis |
6.5% |
| Orthostatic Hypotension |
6.5% |
| Renal Failure Acute |
6.5% |
| Sepsis |
6.5% |
| Oedema Peripheral |
4.3% |
| Palpitations |
4.3% |
| Sjogren's Syndrome |
4.3% |
| Agranulocytosis |
2.2% |
| Cardiac Failure |
2.2% |
| Hepatitis |
2.2% |
| Hyperkalaemia |
2.2% |
| Interstitial Lung Disease |
2.2% |
| Pancreatitis Acute |
2.2% |
| Pulmonary Fibrosis |
2.2% |
| Renal Failure |
2.2% |
| Respiratory Distress |
2.2% |
|
| Concomitant |
| Hypertension |
25.7% |
| Product Used For Unknown Indication |
17.4% |
| Drug Use For Unknown Indication |
14.5% |
| Generalised Oedema |
3.9% |
| Acute Lymphocytic Leukaemia |
3.3% |
| Osteoarthritis |
3.3% |
| Depression |
3.0% |
| Rheumatoid Arthritis |
3.0% |
| Musculoskeletal Pain |
2.6% |
| Prostatitis |
2.6% |
| Thrombosis Prophylaxis |
2.6% |
| Atrial Fibrillation |
2.3% |
| Prostate Cancer |
2.3% |
| Asthma |
2.0% |
| Breast Cancer |
2.0% |
| Cardiovascular Disorder |
2.0% |
| Deep Vein Thrombosis |
2.0% |
| Diabetes Mellitus |
2.0% |
| Multiple Myeloma |
2.0% |
| Benign Prostatic Hyperplasia |
1.6% |
|
| Renal Failure |
9.8% |
| Acute Myeloid Leukaemia |
8.2% |
| International Normalised Ratio Increased |
6.6% |
| Overdose |
6.6% |
| Vascular Purpura |
6.6% |
| Cerebral Haematoma |
4.9% |
| Hypotension |
4.9% |
| Malaise |
4.9% |
| Pancytopenia |
4.9% |
| Rash |
4.9% |
| Renal Failure Acute |
4.9% |
| Renal Impairment |
4.9% |
| Weight Increased |
4.9% |
| Cardiac Arrest |
3.3% |
| General Physical Health Deterioration |
3.3% |
| Haematoma |
3.3% |
| Ischaemic Stroke |
3.3% |
| Melaena |
3.3% |
| Pulmonary Embolism |
3.3% |
| Rib Fracture |
3.3% |
|
| Interacting |
| Drug Use For Unknown Indication |
47.1% |
| Cardiomyopathy |
17.6% |
| Atrial Fibrillation |
11.8% |
| Pain |
11.8% |
| Benign Prostatic Hyperplasia |
5.9% |
| Hypothyroidism |
5.9% |
|
| Shock |
33.3% |
| Hyponatraemia |
16.7% |
| Inappropriate Antidiuretic Hormone Secretion |
16.7% |
| Renal Failure |
16.7% |
| Syncope |
16.7% |
|
